Scienture Holdings, Inc

SCNXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

41.1M

on 2026-06-30, from 1.41M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$200.0M

S-3 of 2025-08-01. 1 prospectus supplement filed under it since. S-3 ↗

$9.2M

Maxim Group, agreement of 2025-09-23. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

190K

Warrants of every class as tagged in the XBRL facts on 2024-03-31. 10-Q ↗

Cash

2.3 quarters

$8.2M on 2026-06-30 ÷ $3.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-08-13	Registered direct offering	3,225,000	$1.20	$3.9M	424B5 ↗
2025-08-13	Registered direct offering	3,225,000	not read	not read	8-K ↗
2025-07-24	Private placement	754,716	$1.59	not stated	8-K ↗

Also on file: $3.3M convertible notes, 2024-11-22 8-K ↗